Targeting EML4-ALK gene fusion variant 3 in thyroid cancer

Finding targetable gene fusions can expand the limited treatment options in radioactive iodine-refractory (RAI-r) thyroid cancer. To that end, we established a novel cell line ‘JVE404’ derived from an advanced RAI-r papillary thyroid cancer (PTC) patient, harboring an EML4-ALK gene fusion variant 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Aydemirli, Mehtap Derya, van Eendenburg, Jaap D H, van Wezel, Tom, Oosting, Jan, Corver, Willem E, Kapiteijn, Ellen, Morreau, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183637/
https://www.ncbi.nlm.nih.gov/pubmed/33878728
http://dx.doi.org/10.1530/ERC-20-0436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183637/
https://www.ncbi.nlm.nih.gov/pubmed/33878728
http://dx.doi.org/10.1530/ERC-20-0436

Ejemplares similares